The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

(2011) James W.F. Catto et al.   EUROPEAN UROLOGY

The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review

(2011) Rianne J.M. Lammers et al.   EUROPEAN UROLOGY

A contemporary standard for morbidity and outcome after radical cystectomy

(2009) Vijay A.C. Ramani et al.   BJU INTERNATIONAL

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

(2009) J. W.F. Catto et al.   CANCER RESEARCH

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer

(2009) Girish S. Kulkarni et al.   EUROPEAN UROLOGY

Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

(2009) Paramananthan Mariappan et al.   EUROPEAN UROLOGY

Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer

(2009) B. K. Hollenbeck et al.   JNCI-Journal of the National Cancer Institute

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

(2009) Richard E. Hautmann et al.   WORLD JOURNAL OF UROLOGY

Invasive T1 bladder cancer: indications and rationale for radical cystectomy

(2008) John P. Stein et al.   BJU INTERNATIONAL